// Evidence Grader
Claim grades, A through F
Every major genomics claim in this course gets a transparent grade — from clinically established interventions to outright misleading marketing. Use this dashboard to audit what's settled, what's preliminary, and what's hype.
A
Clinically established
B
Supported, context-specific
C
Promising, preliminary
D
Plausible, unproven
E
Popular, weak support
F
Misleading or false
Filtered:← Back to module
B
Base editing achieves clinically meaningful PCSK9 lowering after a single in-vivo LNP infusion
VERVE-101 readout interrupted by a transient ALT signal; VERVE-102 with revised LNP underway.
Module 09 · CRISPR Therapeutics: From Casgevy to In Vivo →